These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1. Girolami A; Dal Bo Zanon R; Procidano M Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):863-71. PubMed ID: 6176512 [TBL] [Abstract][Full Text] [Related]
6. Fetal factor VIII and IX levels in early pregnancy and their significance in prenatal diagnosis. Fortune WA; Cox JR Acta Haematol; 1973; 49(5):314-7. PubMed ID: 4198913 [No Abstract] [Full Text] [Related]
7. The comparison of CS-2500 and BCS XP coagulation analyzers for Factor VIII and Factor IX one-stage clotting assays. Genc S; Aydin AF; Karaca E; Ömer B Int J Lab Hematol; 2019 Oct; 41(5):e124-e127. PubMed ID: 31034727 [No Abstract] [Full Text] [Related]
8. The preparation of an artificial reagent for the one-stage factor VIII assay. Nyman D Thromb Diath Haemorrh; 1970 May; 23(2):206-12. PubMed ID: 5426208 [No Abstract] [Full Text] [Related]
9. A simple inhibitor screen is more sensitive than a Bethesda assay in monitoring for the development of inhibitors in haemophilia A and B. Keeling D; Beavis J; Sukhu K Br J Haematol; 2005 Mar; 128(6):885. PubMed ID: 15755295 [No Abstract] [Full Text] [Related]
10. [Determination of the deficient factor in hemophilic patients]. Peñaloza-Santillán JA; Arias y Arias J; Resano-Pérez F Bol Med Hosp Infant Mex; 1975; 32(1):51-9. PubMed ID: 1109289 [No Abstract] [Full Text] [Related]
12. [Thromboplastin generation test and possible errors in its reproducibility]. Tarasova LN Lab Delo; 1980; (11):669-71. PubMed ID: 6160299 [No Abstract] [Full Text] [Related]
13. [An unified method of one-stage quantitative analysis of factors VIII and IX. I. (Results of the studies of the working group of the All-Union Problem-Solving Commission on "Pathology of hemostasis")]. Barkagan ZS Gematol Transfuziol; 1991 Apr; 36(4):33-5. PubMed ID: 1906034 [No Abstract] [Full Text] [Related]
14. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia. Ahnström J; Berntorp E; Lindvall K; Björkman S Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163 [TBL] [Abstract][Full Text] [Related]
15. [Dentition restoration in hemophilia under substitution of AHG concentrates]. Tetsch P; Esser E Dtsch Zahnarztl Z; 1972 May; 27(5):399-404. PubMed ID: 4112700 [No Abstract] [Full Text] [Related]
16. [Laboratory diagnosis of hemophilias]. Egli H Dtsch Med J; 1968 Jul; 19(14):495-9. PubMed ID: 5305712 [No Abstract] [Full Text] [Related]
17. Factor assay (VIII and IX) results in the College of American Pathologists Survey Program (1980-1982). Christensen RL; Triplett DA Am J Clin Pathol; 1983 Oct; 80(4 Suppl):633-42. PubMed ID: 6414289 [TBL] [Abstract][Full Text] [Related]
18. [Assay procedures of blood coagulation factors. Phase I]. Fujimaki M; Yasui T Rinsho Byori; 1969; 16():Suppl 16:75-84. PubMed ID: 5391588 [No Abstract] [Full Text] [Related]